ClinicalTrials.Veeva

Menu

Prevalence of Secondary Hyperparathyroidism Among Patients With Diabetic Nephropathy

B

Benha University

Status

Completed

Conditions

Diabetic Nephropathies
Secondary Hyperparathyroidism

Treatments

Diagnostic Test: intact parathyroid hormone level

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT03137316
BN-0418

Details and patient eligibility

About

The aim of this study is to evaluate the prevalence of secondary hyperparathyroidism among patients with diabetic nephropathy.

Enrollment

437 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • [1] Age was above 18 years, [2] Patient had diabetic nephropathy which was diagnosed based on the presence of urinary albumin/creatinine ratio (uACR) ≥ 30 mg/gm ± 24 hours' urinary protein measurement ≥ 300 mg/day

Exclusion criteria

  • [1] patients were already receiving cinacalcet and/or [2] patients had undergone neck surgery for parathyroidectomy.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems